FREQ Frequency Therapeutics Inc

Price (delayed)

$9.97

Market cap

$341.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.26

Enterprise value

$216.6M

Highlights
FREQ's quick ratio has surged by 119% year-on-year and by 25% since the previous quarter
Frequency Therapeutics's equity has decreased by 8% from the previous quarter but it has increased by 8% YoY
FREQ's net income has dropped by 135% year-on-year and by 58% since the previous quarter
FREQ's EPS has shrunk by 54% QoQ

Key stats

What are the main financial stats of FREQ
Market
Shares outstanding
34.22M
Market cap
$341.16M
Enterprise value
$216.6M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.92
Price to sales (P/S)
9.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.3
Earnings
Revenue
$34.37M
EBIT
-$42.07M
EBITDA
-$40.11M
Free cash flow
-$68.17M
Per share
EPS
-$1.26
Free cash flow per share
-$2
Book value per share
$5.19
Revenue per share
$1.01
TBVPS
$7.08
Balance sheet
Total assets
$241.51M
Total liabilities
$64.1M
Debt
$46.48M
Equity
$177.41M
Working capital
$181.16M
Liquidity
Debt to equity
0.26
Current ratio
10.58
Quick ratio
10.4
Net debt/EBITDA
3.11
Margins
EBITDA margin
-116.7%
Gross margin
100%
Net margin
-122.1%
Operating margin
-122.5%
Efficiency
Return on assets
-17.8%
Return on equity
-23%
Return on invested capital
-158.3%
Return on capital employed
-18.9%
Return on sales
-122.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FREQ stock price

How has the Frequency Therapeutics stock price performed over time
Intraday
-1.68%
1 week
3.42%
1 month
15.53%
1 year
-55.29%
YTD
-71.72%
QTD
4.95%

Financial performance

How have Frequency Therapeutics's revenue and profit performed over time
Revenue
$34.37M
Gross profit
$34.37M
Operating income
-$42.09M
Net income
-$41.97M
Gross margin
100%
Net margin
-122.1%
Frequency Therapeutics's net margin has plunged by 148% YoY and by 70% from the previous quarter
FREQ's net income has dropped by 135% year-on-year and by 58% since the previous quarter
FREQ's operating margin has shrunk by 117% YoY and by 64% QoQ
FREQ's operating income has dropped by 106% year-on-year and by 53% since the previous quarter

Growth

What is Frequency Therapeutics's growth rate over time

Valuation

What is Frequency Therapeutics stock price valuation
P/E
N/A
P/B
1.92
P/S
9.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.3
FREQ's EPS has shrunk by 54% QoQ
The stock's price to book (P/B) is 51% less than its last 4 quarters average of 3.9
Frequency Therapeutics's equity has decreased by 8% from the previous quarter but it has increased by 8% YoY
The stock's price to sales (P/S) is 48% less than its last 4 quarters average of 19.1
Frequency Therapeutics's revenue has decreased by 7% QoQ and by 5% YoY

Efficiency

How efficient is Frequency Therapeutics business performance
FREQ's ROS has shrunk by 119% YoY and by 65% QoQ
FREQ's return on assets has dropped by 102% year-on-year and by 55% since the previous quarter
The return on equity has dropped by 100% year-on-year and by 55% since the previous quarter

Dividends

What is FREQ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FREQ.

Financial health

How did Frequency Therapeutics financials performed over time
The current ratio has soared by 120% YoY and by 25% from the previous quarter
FREQ's quick ratio has surged by 119% year-on-year and by 25% since the previous quarter
Frequency Therapeutics's debt is 74% less than its equity
FREQ's debt to equity is up by 8% since the previous quarter
Frequency Therapeutics's equity has decreased by 8% from the previous quarter but it has increased by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.